Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Creatine kinase B pseudogene 1 (CKBP1) refers to a single-copy non-functional DNA sequence on chromosome 16p13 that shares high sequence similarity with the functional Creatine kinase B (CKB) gene, which encodes an important cytoplasmic enzyme involved in cellular energy homeostasis[6]. CKBP1 is a pseudogene, meaning it does not produce a functional protein product and has no known roles in normal physiology, disease, or as a drug target. Most scientific and medical databases do not list this pseudogene as a biologically relevant target, and it is not involved in molecular pathways, diseases, or drug interactions[6][1][4]. If you are seeking information about the functional enzyme, search for "creatine kinase B" (CKB), not this pseudogene. If your query refers to a functional target, this entry should be considered incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Creatine kinase B pseudogene 1 (CKBP1).